Anthony Martin

Anthony Martin has extensive experience in the life sciences and medical industries. Anthony began their career in 2003 as the Director and Managing Partner of Anthony Martin Advisory (AMA). Anthony then served as the Chairman, Non Executive Director at Phico Therapeutics Ltd. in 2010, Immune Regulation Ltd. in 2016, and Wound Solutions Ltd. in 2006. In 2013, they joined Orthofix NV as a Non Executive Director and ABCAM PLC in 2011 in the same role. Anthony was also the Chairman, Non Executive Director of Sphere Medical Holding PLC from 1997 to 2005 and NeuTec Pharma PLC from 1997 to 2002. In 2002, they took on the role of Chairman and CEO of Molecular Probes Inc., and in 1999 they were appointed President of the Molecular Biology Division of Invitrogen Corporation.

Anthony Martin completed a General Management Programme at the London Business School from 1985 to 1987, a Doctor of Philosophy (PhD) at The University of Manchester from 1976 to 1979, and a Bachelor of Applied Science (BASc) at The University of Huddersfield from 1972 to 1976, with a field of study in Chemistry with Biochemistry.